US Patent 11634486 Anti-SEZ6L2 antibodies and antibody drug conjugates
Patent 11634486 was granted and assigned to Bluefin Biomedicine on April, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 22, 2017
0
Date of Patent
April 25, 2023
0
Patent Applicant
Patent Application Number
16471246
0
Patent Inventor Names
Jason G. Beaudet
0
Scott Michael Lonning
0
Nels Eric Pederson
0
Klarisa Rikova
0
Aleksandr Tkachev
0
Kevin Jefferies
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11634486 Anti-SEZ6L2 antibodies and antibody drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
